News
EKSO
4.290
+5.41%
0.220
Ekso Bionics enters distribution agreement with MediTourch
TipRanks · 1d ago
EKSO BIONICS INKS AGREEMENT TO BECOME THE EXCLUSIVE U.S. DISTRIBUTOR OF MEDITOUCH’S GROUNDBREAKING BALANCETUTOR™ REHABILITATION SYSTEM
Reuters · 1d ago
Weekly Report: what happened at EKSO last week (1124-1128)?
Weekly Report · 5d ago
China Flags Humanoid Robot Bubble Risk as Investor Hype Grows
TipRanks · 11/27 12:12
Weekly Report: what happened at EKSO last week (1117-1121)?
Weekly Report · 11/24 09:49
Ekso Bionics (EKSO) Upgraded to Buy: Here's Why
NASDAQ · 11/21 17:00
Earnings Momentum Lifts PACS And Nutex; Zynex And Genenta Also Advance After Hours
NASDAQ · 11/20 04:43
Ekso Bionics Holdings Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 11/18 15:52
Ekso Bionics Holdings Price Target Raised to $6.00/Share From $4.00 by HC Wainwright & Co.
Dow Jones · 11/18 15:52
HC Wainwright & Co. Maintains Buy on Ekso Bionics Holdings, Raises Price Target to $6
Benzinga · 11/18 15:42
Ekso Bionics’ Strong Q3 2025 Recovery and Strategic Prospects Lead to Buy Rating
TipRanks · 11/18 15:35
Ekso Bionics price target raised to $6 from $4 at H.C. Wainwright
TipRanks · 11/18 15:30
EKSO BIONICS HOLDINGS, INC. <EKSO.O>: H.C. WAINWRIGHT RAISES TARGET PRICE TO $6 FROM $4
Reuters · 11/18 15:26
U.S. RESEARCH ROUNDUP- Autodesk, Crowdstrike, Zscaler
Reuters · 11/18 07:40
Weekly Report: what happened at EKSO last week (1110-1114)?
Weekly Report · 11/17 09:49
Top Executives Make Major Moves with EKSO BIONICS Stock!
TipRanks · 11/13 02:14
Ekso Bionics CFO Jerome Wong Reports Disposal of Common Shares
Reuters · 11/12 22:06
Ekso Bionics CEO Scott G. Davis Reports Disposal of Common Shares
Reuters · 11/12 22:04
Weekly Report: what happened at EKSO last week (1103-1107)?
Weekly Report · 11/10 09:48
Ekso Bionics Announces Executive Equity Award Grants
TipRanks · 11/07 22:30
More
Webull provides a variety of real-time EKSO stock news. You can receive the latest news about Ekso Bionics through multiple platforms. This information may help you make smarter investment decisions.
About EKSO
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.